Mitesh

/Mitesh

About Mitesh

This author has not yet filled in any details.
So far Mitesh has created 140 blog entries.

MHRA Drug Safety Update: February 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 7 February 2024) has been published and includes articles on: Codeine linctus (codeine oral solutions): reclassification to prescription-only medicine Pseudoephedrine: very rare risk of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS) Letters and medicine recalls sent [...]

The post MHRA Drug Safety Update: February 2024 appeared first on Community Pharmacy England.

By |February 20th, 2024|drug safety, Lexpos News, mhra, safety|Comments Off on MHRA Drug Safety Update: February 2024

MHRA Class 3 Medicines Recall: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited)

Drug alert number: EL (24)A/05 Date issued: 12 February 2024 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited) PL 36687/0222 SNOMED Code: 36834211000001109 Batch Number Expiry Date Pack Size First Distributed MG21264 29/02/2024 28 tablets 13/12/2021 MG21334 31/03/2024 28 tablets [...]

The post MHRA Class 3 Medicines Recall: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited) appeared first on Community Pharmacy England.

By |February 13th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited)

Early advance payment timetable for 2024

Pharmacy owners should submit their January 2024 FP34C submission figures through the Manage Your Service (MYS) portal by the end of 5 February 2024 to receive earlier advance payments on Friday 9 February 2024. The 100% advance payments will continue to be based on the items declared on the FP34C and the latest available Average Item Value [...]

The post Early advance payment timetable for 2024 appeared first on Community Pharmacy England.

By |February 5th, 2024|Lexpos News|Comments Off on Early advance payment timetable for 2024

Class 4 Medicines Defect Information: Pantoprazole 40 mg gastro-resistant tablets (Cadila Pharmaceuticals (UK) Limited)

Class 4 Medicines Defect Information: Pantoprazole 40 mg gastro-resistant tablets (Cadila Pharmaceuticals (UK) Limited) Drug alert number: EL (24)A/03 Date issued: 30 January 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Pantoprazole 40 mg gastro-resistant tablets (Cadila Pharmaceuticals (UK) Limited) Company name: Cadila Pharmaceuticals [...]

The post Class 4 Medicines Defect Information: Pantoprazole 40 mg gastro-resistant tablets (Cadila Pharmaceuticals (UK) Limited) appeared first on Community Pharmacy England.

By |January 30th, 2024|Lexpos News|Comments Off on Class 4 Medicines Defect Information: Pantoprazole 40 mg gastro-resistant tablets (Cadila Pharmaceuticals (UK) Limited)

MHRA Drug Safety Update: January 2024

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 6 January 2024) has been published and includes articles on: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): new safety and educational materials to support regulatory  measures in men and women under 55 years [...]

The post MHRA Drug Safety Update: January 2024 appeared first on Community Pharmacy England.

By |January 22nd, 2024|Lexpos News|Comments Off on MHRA Drug Safety Update: January 2024